FH HES
Universities of Applied Sciences
Fachhochschulen – Hautes Ecoles Spécialisées
Analytical Platforms at Swiss Universities of Applied Sciences
Christian Berchtolda, Jean-Pascal Bourgeoisb, Verena Christena, Michal Dabrosb, Caspar Demuthd, Anika Hoffmannc, Franka Kalmanc, Susanne Kernd, Nadia Marconc, Olivier Nicoletb, Marc E. Pfeiferc, Umberto Piantinic, Denis Primc, Cyril Portmannb, Samuel Rothb, Jean-Manuel Segurac, Olivier Vorletb, Chahan Yeretziand, Mathieu Zollingerc, and Götz Schlotterbeck*a
*Correspondence:Prof. Dr. G. Schlotterbecka, E-mail: [email protected]
aFHNW Fachhochschule Nordwestschweiz, Hochschule für Life Sciences, Institut für Chemie und Bioanalytik, Hofackerstrasse 30, CH-4132 Muttenz;
bHES-SO Haute école spécialisée de Suisse occidentale, Haute école d’ingénierie et d’architecture Fribourg, Institute of Chemical Technologies, Boulevard de Pérolles 80, CH-1700 Fribourg;
cHES-SO Haute école spécialisée de Suisse occidentale, HES-SO Valais-Wallis, Institute of Life Technologies, Route du Rawyl 64, CH-1950 Sion 2;
dZHAW Zürcher Hochschule für Angewandte Wissenschaften, Life Sciences and Facility Management, Institute of Chemistry and Biotechnology, CH-8820 Wädenswil
Abstract:Numerous projects and industrial and academic col- laborations benefit from state-of-the-art facilities and expertise in analytical chemistry available at the Swiss Universities of Applied Sciences. This review summarizes areas of expertise in analytical sciences at the University of Applied Sciences and Arts Northwestern Switzerland (FHNW), the University of Applied Sciences and Arts Western Switzerland (HES-SO), and the Zurich University of Applied Sciences (ZHAW). We briefly discuss selected projects in different fields of analytical sci- ences
Keywords: Analytical chemistry · Applied Research ·
Bioanalytics · DAR · Diagnostics · Next-generation point-of-care diagnostic systems · Universities of Applied Sciences
Introduction
Analytical platforms are highly interdisciplinary and are of great importance to support all fields of research. The technol- ogy and instrumentation, based on sophisticated and expensive infrastructure, is as important as the experts who know how to use, improve and optimize the techniques as well as to support the interpretation of results. In the focus of the Universities of Applied Science for education and research, it is important to provide state-of-the-art technology to train students in applied research and to support their own research projects. The main difference to classical universities is the reduced need for cutting- edge instrumentation for fundamental research (like ultra-high field NMR spectrometers or ultra-high resolution mass spectrom- eters). Robust state-of-the-art technologies for business oriented and applied research are needed instead. However, the analytical platforms at the Universities of Applied Sciences in Switzerland are extremely diverse according to their focus, purpose and needs. The purely supporting platforms such as NMR- and mass spec. services, which are run by dedicated experts within the in- stitutions as a routine service, is one common approach. Another setting is the distribution of instruments within each institute as dedicated support for experts in other fields. This means for ex- ample that researchers in organic chemistry run their own instru-
ments (e.g. HPLC, MS, NMR) to follow reactions and perform quality control. Sometimes such platforms are partially orga- nized as open-access facilities, where a dedicated team maintains instruments and each scientist uses these open-access systems on a need basis.
Finally, there are independent multidisciplinary analytical platforms that run their own instruments, perform their own projects for method and instrument development and support other teams inside and outside the institution with analytical expertise and instrumentation. The techniques used in all these fields where analytical platforms play a key role, as well as how they are organized within the different institutions, is as diverse as the different research and education models. This article provides an overview of analytical platforms, projects infrastructure and focus of the Universities of Applied Science across Switzerland.
FHNW Muttenz
The School of Life Sciences conducts research and educa- tion along the entire healthcare and value creation chain. The spectrum ranges from the development of medical products and drugs, technologies and production processes through to their production and market launch. An additional focus is the devel- opment of resource-saving technologies and environmental pro- cedures. The research is organized within four institutes and each runs its own infrastructure for analytical support, development and training.
TheinstituteforMedicalEngineeringandMedicalInformatics (IM2) needs mostly surface analytical tools (e.g. REM, ultra- sound, X-ray diffraction) for the development of functional ma- terials, implant design and Biofabrication (3D-Bioprinting).
The Institute of Pharma technology (IPT) conducts research into new technologies and methods for pharmaceutical products.
The fields are bioprocess technology, drug delivery and PK/PD, formulation and devices for active chemical and biological sub- stances, oral formulations of chemical drugs and production pro- cesses and techniques. Among other technologies, LC-MS and capillary electrophoresis are used for quality control processes and to investigate effects of drugs and formulations on organisms within cell models. Neither IM2nor IPT runs a dedicated analyti- cal platform. Their instruments are specifically located among the teams who need them as tools and use the other platforms of the other institutes in collaboration.
The Institute for Ecopreneurship (IEC) for environment and resources performs research and education in the fields of envi- ronmental and water technologies, environmental biotechnology, ecotoxicology and sustainable resources management. This insti- tute provide the main platform for inorganic, elemental analysis (e.g. LC-QQQ-ICP-MS, laser ablation, ICP-OES,µXRF, XRF, SEM, EVO SEM). For organic analysis an additional platform is present for direct support (e.g. LC, LC-OCD, LC-MSn - QqQ and Ion Trap, GC-MS, MALDI-TOF). The radioisotope analysis platform is also integrated within a specialized radiology labo- ratory (14C and3H, liquid scintillation, autoradiography, HPLC with liquid scintillation detector, sample Oxidizer). Molecular bi- ology (quantitative PCR, next generation sequencing platforms, electrophoresis), which also supports other institutes, is also lo- cated at the IEC.
The Institute for Chemistry and Bioanalytics (ICB) provides research in synthesis and medical chemistry, nanomaterials and surfaces molecular nanotechnology, process engineering and technology, in vitro diagnostics, DNA and RNA diagnostics, pro- tein and tissue engineering, cell biology and toxicology as well as instrumental analytics.
A large analytical platform for nanomaterials and surfaces molecular nanotechnology such as a variety of microscopes (e.g.
TEM, SEM, EDX, AFM, infrared- and Raman imaging, LEXT), spectroscopy and other technologies (e.g.µCT) is located in the group of Prof. Dr. Uwe Pieles and were described already last year in an article about material sciences.[1]
DNA and RNA diagnostics, cell biology and toxicology focus on molecular techniques such as qPCR or NGS. This platform is highly cooperative and overlaps with the platform at the Institute of Ecopreneurship (IEC).
For the development of point of care devices (for in vitro diag- nostics), surface plasmon resonance and bio-layer interferometry play a key role as analytical tools. Therefore, a dedicated plat- form for the analysis of protein–ligand interactions exists as well.
The group of Prof. Dr. Götz Schlotterbeck represents the main analytical research and runs the instrumental analytical in- frastructure of HPLC, GC, LC-MS, GC-MS and NMR (400 MHz NMR, LC/GC single quads, LC/GC triple quad, GC-TOF, LC-Q- TOF, LC - Ion Trap and OrbiTrap). These techniques are not only support for the other groups within the institute and FHNW (e.g.
for medical chemistry or chemical engineering), also analytical research and training for diagnostics, food and environmental analytics, structure elucidation, metabolomics and proteomics is done there. The following exemplary projects show some typical collaborations between external partners and several institutes in analytical chemistry and are exemplary for the research per- formed at FHNW.
Targeted, Correlative Single-cell Proteomics and Metabolomics
The characterization of the metabolite and protein expression on a single-cell level are important to understand the underlying mechanisms of cellular processes. Picking, lyzing and spotting of the content of single cells on the surface of microscope slides was introduced by the team of Prof. Dr. Thomas Braun at Uni Basel (C-Cina, Biozentrum).[2,3]A self-made interface based on a TLC-MS interface (CAMAG, Muttenz, BL) was used to extract, transfer and detect a few metabolites (glutamic acid, glutamine and dopamine) by LC-MS down to single cell level. The pro- teins remaining on the glass slide were antibody stained (thanks for support of Dr. Gregor Dernick, F. Hoffmann-La Roche). The antibody staining is still possible after the metabolite extraction and analysis by LC-MS from the same cell thus enabling a cor- relative analysis.
The results of this fundamental proof of concept study are shown in Fig. 1. This project was supported by SNF project 200021_162521 (for the cell picker development) and nano ar- govia A.9.12 (for mass spectrometry interface and Roche col- laboration on visual proteomics) as well as an internal FHNW collaboration of ICB and IPT.
Automated Dried Blood Spot Analysis for Newborn Screening
All approx. 80’000 newborns in Switzerland are screened for a list of serious genetic and metabolic disorders. Early diagnosis of those conditions can help prevent their further development, which untreated can result in brain damage, organ damage, and even death (www.neoscreening.ch). The dried blood spots (DBS) are sampled on-site by a nurse and analyzed in a centralized laboratory.[4]To optimize the process and the sample tractabil- ity, a fully automated DBS extraction system for online mass
spectrometry coupling was developed by CAMAG (https://dbs.
camag.com/dbs-ms-500; Fig. 2). In a joint effort between the University of Applied Sciences FHNW, the newborn screening laboratory of the children’s Hospital Zürich and CAMAG, a new mass spectrometry-based screening method for amino acids, ac- ylcarnitins, and steroids was developed and implemented (CTI Project: 16898.1 PFLS-LS).[5–7]
Fig. 1. Left: The visual appearance of the used SH-SY5Y (neuronal cells). In the middle, mass spectra of single cell metabolites by LC-MS (targeted triple quad). Right: The remaining proteins on the microscope slide detected by fluorescent antibodies in an IR-scanner.
Fig. 2. a) The CAMAG DBS-500 auto-sampler for DBS cards; b) func- tion scheme of the imaging, extraction process and online external analysis using chromatographic separation and mass spectrometric detection (chromatography and mass spectrometry are not part of the system shown in a)
Personalized Life Style Guiding by Minimum Volume Blood Analysis
This CTI project (18365.2 PFLS-LS) was a collaboration of the startup Sanalytica GmbH/Baze (www.baze.com), the pro- teomics laboratory Biognosy AG (www.biognosys.com) and the diagnostic laboratory SwissAnalysis AG (www.swissanalysis.
ch). The main idea was to support a healthy lifestyle with fre- quent blood testing, using a minimum amount of blood, sampled at home. This frequent testing allows to monitor the effect of a healthy lifestyle and supplementation strategy beyond the classi- cal blood testing at the doctor’s surgery. Methods for fatty acids by GC-MS (FHNW ICB), for vitamins and proteins by LC-MS (FHNW ICB and Biognosy AG) as well as trace elements by ICP-MS (FHNW IEC) were developed. All specialized methods focused on small blood volumes and potential automation, which were finally implemented by SwissAnalysis AG.
The TAP device (www.7sbio.com) was implemented to col- lect approximately 100 microliter of blood at home. The samples were shipped (cooled) to the laboratory, prepared and analyzed by the parallel methods. The results are transferred and displayed in an app, including tips for nutrition and supplement (by Baze).
The concept is shown in Fig. 3.
Gene Expression Analysis in Honey Bees after Exposure to Pesticides
Honey bees, wild bees, and other insects are important pol- linators and thus contribute to securing our food supply and pro- mote biodiversity. In recent years, there has been a sharp decline in the number of insects and an increased mortality rate among bee colonies.[8]Several factors are responsible for this, including exposure to pesticides.[9]It is known that exposure to pesticides causes sublethal, chronic effects in honey bees in addition to acute toxic effects. For example, memory formation, orientation and flight behavior are negatively affected.[10]To identify the un- derlying mechanism of action, honeybees are fed in the labora- tory of FHNW with sugar syrup containing pesticides and gene expression is analyzed after 1, 2 and 3 days of exposure using quantitative PCR and next-generation sequencing (Fig. 4).[11]In
joint projects between the FHNW and Agroscope, the molecular mechanism of action of behavioral changes in honey bees after exposure to pesticides is investigated. The exact exposure con- centrations are determined in the sugar syrup by using HLPC coupled with MS.[12]Honey bee research at FHNW was initially a collaboration with the Federal Office for Agriculture and the Federal Office for the Environment. Current running projects are partially granted and in collaboration with Agroscope.
ZHAW Wädenswil
The Institute of Chemistry and Biotechnology (ICBT) was founded in 2016 as a result of a merger of the former Institute of Chemistry and Biological Chemistry and the Institute of Biotechnology. About 180 lecturers, researchers and scientific staff work at the ICBT. Over 240 students are enrolled in the two Bachelor programs, and more than 70 students in the two Master programs. The ICBT is active in teaching and third-party funded applied research to about the same extent. Many of its research projects have a strong international orientation.
The convergence of biological and chemical sciences results in strong synergies between the institute’s research groups and a very broad scope in applied research. Our understanding of chemistry and biotechnology is that it involves the linking of dis- coveries in the natural sciences with technological knowledge, with the aim of applying biological systems to the analysis and manufacture of products.
In any case, a very sound understanding of analytical methods and instrumentation is required in the different ICBT working groups, even if they do not solely focus on the application and optimization of analytical methods. As a brief and non-compre- hensive overview, selected examples of research groups who ap- ply advanced analytical tools to pursue their activities in applied research are given below. The Centre for Functional Materials and Nanotechnology employs analytical techniques such as scan- ning electron microscopy (SEM/EDX), atomic force microscopy and confocal Raman spectroscopy to characterize surfaces and interfaces (for a review, see ref. [1]). In the Centre of Molecular Biology and Microbiology, among other analytical and bioana- lytical methods, matrix-assisted laser desorption/ionization time- of-flight mass spectrometry (MALDI TOF-MS) of the newest generation is used for the identification of microorganisms and the qualitative analysis of (bio)macromolecules. The Centre for Biochemistry and Bioanalytics applies high-resolution LC-MS/
MS (ESI-Q-TOF) to generate information about sequences and post-translational modifications of proteins. Mass spectrometry,
Fig. 3. Concept of home sampling and testing. The TAP device is send to the laboratory for analysis (amino acids, vitamin D/E, and proteins by LC-MS, fatty acids by GC-MS, and trace elements by ICP-MS). The results are displayed online or by app to adjust the diet and supplement strategy.
Fig. 4. Graphical overview of honey bee exposure. Honey bee workers are exposed with sugar syrup containing pesticides for 1, 2 and 3 days followed by gene expression analysis in the brain and chemical analysis of exposure solution.
capillary electrophoresis and ion chromatography are used to analyze complex glycosylation patterns of recombinant proteins.
Ligand–analyte interactions are examined in label-free real-time measurements using surface plasmon resonance spectroscopy.
Many of ICBT’s research groups are dedicated to chemical and biochemical engineering and bioprocess technology. These groups make use of process analytical methods, such as inline spectroscopy (IR, NIR, Raman, UV/Vis, fluorescence, for de- tails see ref. [13]), inline particle measurements (focused beam reflectance measurement, photon density wave spectroscopy), or analytical methods that are coupled online to bioprocesses, such as flow cytometry and HPLC.
In the following, a brief overview of the research activities and selected projects in the Centre for Analytical Chemistry is given. Here, four different research groups dedicate their work to the development and application of analytical methods. The Analytical Technologies group is engaged in developing and vali- dating analytical methods with a focus on chromatography, mass spectrometry and time-resolved real-time technologies, with a particular emphasis on statistical data analysis and chemomet- rics. Attached to the Analytical Technologies group, the Coffee Excellence Center is a leading public research group in the field of coffee. Together with worldwide partners, it works on proj- ects along the entire value chain of coffee. The Environmental Analysis group is concerned with identifying and quantifying organic substances and chemical elements in environmental samples and materials at trace levels. In the Measurement and Sensor Technology group, sensors and other analytical methods are developed and applied that are suitable for online monitor- ing and control of (bio)processes. The Physical Chemistry group focuses on molecular spectroscopy in the infrared (IR, NIR) and UV spectral range and electrochemical methods.
Analytical Technologies
The groups for Analytical Technologies and the Coffee Excellence Center are closely connected while having dis- tinct and complementary orientation. The group for Analytical Technologies is dedicated to developing and refining state-of-the art analytical technologies with a focus on direct-injection real- time mass-spectrometry of mostly volatile organic compounds (VOC). Analytical technologies including couplings to processes and data analysis are at the center of the research effort. In this context, the two key technologies are proton-transfer-reaction time-of-flight mass spectrometry (PTR-ToF-MS),[14,15]and ion- mobility time-of-flight mass spectrometry (IM-ToF-MS).[16] In the following an example of a technological development in the fields of PTR-ToF-MS and IM-ToF-MS are outlined.
Development of Improved Nose-Air Sampling Technology by PTR-ToF-MS
Analyses of mouth and nose-spaces have been used abun- dantly in research over the past few decades for medical pur- poses as well as for sensory analysis.[17–19]All of these sampling methods have been using the analysis of the respiratory flow to determine the content of volatiles present in the lungs, the mouth or the nasal cavity. With regard to sensory analysis, this means that the compounds of interest that accumulate in the mouth and nasal cavity become diluted by the respiratory flow, leading to low signal intensities and consequently only a limited number of flavor active compounds can be monitored. Hence, one aspect of the research in our laboratory is to increase the signal intensity when sampling VOCs present in the mouth cavity.
To this end, we have tested, compared and optimized three different sampling methods: (i) Nose-space sampling of the exha- lation stream (with nose-piece); (ii) mouth-space sampling of the exhalation stream, using a Buffered End-Tidal breath sampling inlet (BET) by Ionicon; (iii) direct mouth-space: drawing sample
gas directly from the mouth cavity while breathing through the nose - mouthpiece from BET (non-re-breathing mouthpieces) coupled to a sampling and dilution lance.[20]A schematic of this setup is shown in Fig. 5.
The measurements of seven different coffees have revealed the same order of magnitude in differences between the three sampling methods. Fig. 6 shows two series of graphs. The se- ries to the left depicts the intensities for m/z 153.055 and m/z 153.091, tentatively identified as vanillin and ethylguaiacol re- spectively, which represent signals with the lowest intensity that were still distinguishable from the background. The series to the right shows the intensities of m/z 73.065, m/z 87.080 and m/z 101.0S60, tentatively identified as 2-methylpropanal, 2-/3-meth- ylbutanal and 2,3-pentadione respectively, which represent sig- nals with high intensities.
In summary, the signal area of our new direct mouth-space sampling method was at least a factor of 5 higher in intensity, compared to the indirect mouth-space sampling and a factor of at least 20 higher compared to nose-space sampling.
Fig. 5. Sampling setup with direct mouth-space sampling setup.
Nose-space viaexhalationMouth-space viaexhalationDirectMouth-space
Fig. 6. Comparison of signal intensities of low intensity compounds (to the left) and high intensity compounds (to the right) for three different sampling methods: Upmost panels: nose-space; Middle panels: BET mouth-space; lowest panels: direct mouth-space.
The results from the comparison of the three different sam- pling methods have shown a massive improvement in signal intensity of the newly developed direct mouth-space sampling compared to the other two (conventional) sampling methods. The improvement in signal intensity can be directly linked to the fact that this approach uses a direct sampling of the volatiles pres- ent in the mouth-cavity instead of indirectly sampling these in the exhalation stream. It therefore enables the sensitivity of the measurement to be increased under otherwise equal conditions such as time resolution and a given measurement setup. Thereby, the direct mouth-space method enables a more sensitive dynamic measurement of volatiles during the aftertaste or lingering phase following the ingestion of food or drinks.
Online Analysis of Coffee Roasting with Ion Mobility Spectrometry–Mass Spectrometry (IMS–ToF-MS)
Online analysis of coffee roasting was performed using ion mobility spectrometry–mass spectrometry (IMS–MS) with co- rona discharge ionization. This is the first time that the formation of volatile organic compounds (VOCs) during coffee roasting was monitored using ion mobility spectrometry, in positive and in neg- ative ion mode.[16]The temporal evolution of more than 150 VOCs was monitored during the roasting of Brazilian Coffea arabica.
Mass-selective ion mobility spectrometry allowed a separation of isobaric and isomeric compounds. In positive ion mode, isomers of alkyl pyrazines were found to exhibit distinct time-intensity profiles during roasting, providing a unique insight into the com- plex chemistry of this important class of aroma active compounds.
Negative ion mode gave access to species poorly detectable by other online methods, such as acids. In this study, the release of fatty acids during coffee roasting was investigated in detail. These increase in the early phase of the roasting process, followed by a decrease at the later phase, as other VOCs start to be formed.
Normalized ion mobility spectra of some fatty acids are shown in Fig. 7. For fatty acids with the same number of carbon atoms, the IMS peaks shift to shorter drift times with increas- ing number of double bonds, indicating a smaller collision cross section for the unsaturated fatty acids. In contrast, prolonging the chain length of the fatty acid increases the drift time and cor- respondingly the collision cross section.
Within this study it was shown that corona discharge coupled to IMS–MS is a powerful tool for online analysis of the temporal evolution of volatile organic compounds, demonstrated here dur- ing coffee roasting. The method exhibits two main advantages:
First, the ion mobility dimension separates based on collision cross section, which often resolves isomers and isobars that can- not be separated by MS alone. This was demonstrated for alkyl pyrazines, which make different coffee aroma contributions de- pending on their alkyl chain lengths and positions, as well as for free fatty acids as discussed here (Fig. 7). The ion mobility spec- tra showed that multiple isomers often contribute to single mass peaks. This is a huge step ahead in comparison to prior direct inlet online monitoring methods which are unable to separate isomers.
Second, the corona ion source provides easy and straightforward access to both positive and negative ions, while prior online methods are restricted to positive ions. This allows the routine observation of a much larger range of chemical species.
Coffee Excellence Center
While the Coffee Excellence Center builds on the expertise and infrastructure on the analytical technology group, its mission is to advance our understanding of coffee, secure its future and support a sustainable grow of the coffee sector along the whole value chain through research, knowledge building and outreach.
From an educational perspective, its goal is to demonstrate the application side of analytical technologies in one specific field of research.
Hence, our research includes investigation of coffee along the whole chain from the seed to the cup. In Fig. 8, PTR-ToF-MS profiles of green coffee, roasted whole bean coffee, roast and ground (R&G) coffee and finally of a coffee brew are shown, all plotted on an identical intensity scale. PTR-ToF-MS is an emerg- ing analytical technique that has first been applied by Yeretzian and co-workers (since 1997) to coffee aroma analysis and is to- day an established technique in the field.[14]While green coffee shows a distinctively different profile of much lower intensities than roasted coffee, grinding the roasted beans leads to a strong increase of the volatile intensities.
The past 10 years have proven that the Coffee Excellence Center is responding to a strong need of a growing and flourish- ing coffee industry. Today the Coffee Excellence Center is work- ing in collaborative projects with most large and multinational companies. In this process, we also take the role of consultants and partners in helping formulate and crystalize their strategies and pipelines. Our involvement and deep knowledge of large number of key actors of the sectors puts us in a unique position, overseeing and understanding trends and opportunities.
Environmental
One of the main research activities of the Environmental group lies in the field of elemental analysis and speciation.
Among other analytical methods, inductively coupled plasma- optical emission spectrometry (ICP-OES), atomic absorption
Fig. 7. IMS spectra of mass peaks corresponding to free fatty acids show multiple isomers/isobars. From bottom to top: c16:0 (m/z 255.22), c18:2 (m/z 279.22), c18:1 (m/z 281.24), c18:0 (m/z 283.25), c20:0 (m/z 311.28), c22:0 (m/z 339.32).
Origin Transformation Release
Roasting Grinding Brewing
Fig. 8. PTR-ToF-MS mass spectra profiles of coffee as green whole beans, roasted whole beans, roast and ground beans and coffee brew.
The volatiles of ground coffee clearly show the strongest overall intensi- ties.
spectroscopy (AAS), and wavelength-dispersive X-ray fluores- cence (WD-XRF) are used. A project to prevent fuel abuse and unauthorized burning of wood was conducted with the regional governments of central Switzerland and the two federal offices of Energy (BFE) and of the Environment (BAFU). Based on the project results, benchmarks to limit heavy metals in wood incin- eration ash were established. A long-term project with the «Spiez Laboratory» focuses on the monitoring of military legacies, i.e.
sites contaminated with toxic heavy metals in Switzerland or conflict areas in other parts of the world.
In a collaboration with Empa, organic pollutants that are used as flame-retardants in polystyrene, were investigated. These in- clude hexabromocyclodecanes (HBCDs) and chlorinated paraf- fins (CPs), as well as their transformation and degradation prod- ucts. Due to their high bioaccumulation potential and suspected cancerogenic properties, these substances are regulated under the Stockholm Convention list of persistent organic pollutants.
However, longer chain chlorinated paraffins are used as substi- tutes with yet unknown transformation products. Considering the various structural isomers of the chloroparaffins, the challenging quantitative determination of these compounds was successfully achieved using LC-MS/MS and LC-QTOF-MS.[21]
Measurement and Sensor Technology
In the Measurement and Sensor Technology group, sensors and related online measurement techniques are developed, opti- mized and applied to various processes, with a special focus on parameters relevant in bioprocess monitoring and control. In these processes, specific requirements have to be taken into account, such as long-term stability, robustness in cleaning and sterilizing procedures, or biocompatibility of materials used. For the bio- technological cultivation of cells and microorganisms, single-use systems have been increasingly used in recent years. As this offers new challenges and perspectives in sensor technology, single-use sensors are among the relevant research topics of the working group. In the following, selected projects are presented. For con- fidentiality reasons, no details can be given, since most of these projects were carried out in collaboration with industrial partners.
For parallel and rapid bioprocess development, small bioreac- tors are increasingly being used, but these offer only limited in- stallation space for sensors. Therefore, robust sensors for critical process parameters (such as the pH value and the concentration of dissolved oxygen, dO) are required that meet the size con- straints of these bioreactors, while still adhering to standardized dimensions of sensor ports. In a project in collaboration with the Bern University of Applied Sciences and an industrial partner, a sensor that combines pH and dO measurement in a slim de- sign was developed and evaluated. Whereas the pH value was measured potentiometrically with a classic glass electrode, an optical measuring method was used to measure the concentration of dissolved oxygen. The optical sensor was based on an immobi- lized dye that changes its fluorescence properties due to selective quenching upon interaction with molecular oxygen. In the course of the project, new features of the sensor were realized, such as a special glass membrane, a light guide, an immobilization technique for the optical sensor material, and the measurement electronics. The built prototypes were evaluated in bioprocesses and compared with other sensor systems. The innovative pH/DO sensor proved to combine the advantages of the potentiometric pH electrodes (high measuring range and robustness) with the benefits of optical dO measurements (high stability and low maintenance requirements).
The concentration of viable biomass is one of the most rel- evant parameters in bioprocess control. For example, online mea- surement of biomass concentration or viable cell density allows to control the culture conditions or to determine the moment of induction of the production of a recombinant protein. Although
offline methods to measure biomass concentration exist, they are time-consuming, may be inaccurate and bear the risk of contami- nation. As an alternative, dielectric spectroscopy has proved to be a valuable tool for real time and in situ measurements of biomass concentration. However, this measurement technique is still rela- tively new, and therefore, the prospects and limits of new applica- tions in bioprocesses have yet to be investigated and understood.
In a collaboration with an industrial partner, a sensor based on dielectric spectroscopy was applied to BHK cells grown on poly- meric microcarriers. Cultivations on microcarriers are especially critical in this respect, as they do not allow the use of optical measurement techniques due to the light-scattering properties of the beads. The investigations showed a very high correlation be- tween online and offline measurements, therefore proving that it is possible to analyze viable cell density of mammalian cells on microcarriers in real-time.[22]
In another project in collaboration with the Institute for Bioprocessing and Analytical Measurement Techniques (Heiligenstadt, Germany), dielectric spectroscopy was used to monitor the growth of hairy root cultures (Fig. 9). Up to now, the growth of these plant organ cultures can only be monitored by applying time-consuming and destructive methods, such as the determination of the dry cell weight. The measurements proved that dielectric spectroscopy can be successfully applied not only to cell suspensions, but also to organ cultures.[23]
In a project in collaboration with the Swiss Federal Institute of Metrology, a new activity scale for sodium, potassium, magnesium, calcium and chloride ions was proposed. This will allow ion activ- ity measurements of these physiologically relevant ions with high
Fig. 9. As the spatial distribution of Hairy Root biomass is not ho- mogeneous, online measurement of these cultures is challenging.
Nevertheless, the sensor signal (a characteristic frequency dependent drop of capacitance Cp) can be correlated to the cultivation time.
comparability and traceability, independent from the measurement systems utilized. This is one important prerequisite for safe and efficient measurements of these ions in clinical laboratories based on ion-selective sensors and other methods. To prove this concept, the Measurement and Sensor Technology group successfully par- ticipated in an interlaboratory comparison, in collaboration with several leading European metrology institutes (Fig. 10).[24]
HEIA-Fribourg
The analytical platform of the Institute of Chemical Technology (ChemTech) at HEIA-Fribourg is formed by several professors working in different fields of chemical characteriza- tion, and includes an Analytical Laboratory Service. Its main pur- pose is to provide strong support to the ChemTech Institute and to the training of our students. The laboratories at HEIA-Fribourg are well equipped with all the essential instrumentation in ana- lytical chemistry (LC, GC, MS, ICP-OES, NMR…), as well as physical chemistry (DSC, TGA, Raman spectroscopy, rheology, Particle Size Distribution...).
Analytical Laboratory Service
From the start of its activity, the main objective of the Analytical Laboratory Service at HEIA-Fribourg was to make the institute’s analytical infrastructure available to the largest possible number of partners and to develop new collaborations with various local economic players.
With more than 15 years of experience, the Service offers its expertise and key skills to support the Institute’s strategic axe of material characterization technology. In particular, it is active in the fields of NMR spectroscopy, gas and liquid chromatography coupled with mass spectrometry, dynamic scanning calorimetry, EDX analysis with a scanning electron microscope and Raman spectroscopy (Fig. 11)).
The Analytical Laboratory Service is facing increasingly more diversified and sophisticated demands, coming primarily from internal R&D projects of the Swiss Universities ofApplied Sciences, but also from external, national industry partners.
The Service has built and maintained long-term, strong re- lationships with its key clients. For example, the Laboratory is
performing a part of the quality control process for a designer and manufacturer of hyaluronic acid dermal fillers and skincare products by measuring density and refractive index. Metalor Technologies SA – a leading participant in the field of precious metals and advanced materials (www.metalor.com) - is a part- ner with whom the Laboratory works together on HPLC reac- tion monitoring. As a last example, the Service collaborated with the R&D laboratory of a well-known watchmaker on molecular structure determination by NMR.
Analytical Chemistry R&D
The ChemTech Institute participates in several projects with other Universities of Applied Sciences, especially in the environ- mental chemistry field. A recent project, named ‘Xyloclean’ and carried out with Prof. R. Röthlisberger from HEIG-VD, aimed to minimize the polluting emissions from wood combustion. For this purpose, the residual HAP were quantified in the emitted par- ticulate matter using GC-MS and a specific extraction technique.
The Institute is now involved in a new project called
‘Conforto’, in collaboration with HEPIA-GE and Prof. B. Oertli.
This project deals with a multi-disciplinary approach to design a new concept of urban water basins with multiple ecosystem services (biodiversity protection, flood regulation, refreshing ef- fect…). The role of the Institute’s analytical platform will be to support the evaluation of the impact of specific urban pollutants and to study the potential use of these basins for water treatment.
The carbon-trapping capacity of these ponds will also be assessed by looking analytically at the CO2exchanges.
In the field of instrumental chemistry, ChemTech is active in the conception, development and production of affordable in- struments. This field of research started about ten years ago with the construction of a budget capillary electrophoresis (ECB) de- signed for the detection of counterfeit medicines.[25]
Building on this experience, the team is now developing a new generation of capillary electrophoresis instrument based on the open-source hardware principle, and looking for new applica- tions for this technology.
Finally, a budget Raman instrument (RAB) was also devel- oped with the idea to offer a portable screening capability to sup- port the identification of counterfeit drugs directly in the field.[26]
Physical Chemistry R&D
Over the past 3 years, a special effort has been made at ChemTech to develop skills in the field of powder characteriza- tion. For this purpose, various student projects have been carried out in order to study the behavior of certain food powders. In par- ticular, the water absorption process and its effect on the physical properties of the powder has been investigated. In addition, phe- nomena such as oxidation and degassing in roast & ground coffee have also been studied. The recent acquisition of an instrument to measure the kinetics of solid sample water intake should allow the Institute to increase our skills further in this area.
PAT & bio-PAT
The ChemTech Institute at HEIA-FR is active in the area of Process Analytical Technology (PAT), applied to both chemistry and bioprocessing.[13]PAT, an initiative proposed by the FDA in 2004, is a systematic analytical approach to designing, analyzing and controlling a process through timely measurements of criti- cal quality and performance attributes, with the goal of increasing process understanding and ensuring final product quality.
The PAT strategy is very useful, for instance, in the field of continuous flow chemistry. Micro- and meso-reactor technology offers many advantages, such as rapid heat and mass transfer, and it has been studied actively at ChemTech over the past several years. In a recent Master project, carried out in collaboration with the fine chemicals industry, the integration of an online process
Fig. 10. Selected results of an interlaboratory comparison based on measurements of ion activities of Mg2+and Ca2+ions. Reference values are displayed in red color, activity values measured by ZHAW are de- picted in column 4.
Fig. 11. The Analytical Laboratory Service.
supervision platform in a mini-CSTR reaction screening system was investigated.[27]The system was designed such that different process monitoring probes (IR, Raman, etc.) could be installed interchangeably, depending on the need, providing a live analyti- cal window into the process and enabling process development, control and optimization.
Several projects have also been conducted on the application of PAT in the field of bioprocess engineering. In one study, online bio- mass monitoring sensors were used to control the specific growth rate of microorganisms and to prevent the production of undesired overflow metabolites.[28]From the control point of view, this task is difficult because of the strong noise present in the online bio- mass concentration signal and due to the non-linear dynamics of the process. In the latest study, a new controller logic was proposed to address these problems.[29]The application of calorimetry as a PAT tool in bioprocessing is currently being investigated.
HES-SO Sion
The Institute of Life Technologies (ITV) is part of the School of Engineering of the HES-SO Valais-Wallis. Analytical Chemistry, Biotechnology and Food Technology are the three educational pillars of the Bachelor of Science degree program while Biotechnology & Sustainable Chemistry, Diagnostic Systems, Food & Natural Products as well as Peptide & Protein Technologies constitute the four research groups of the Institute.
Various platforms, such asAnalytical Chemistry & Biochemistry, strategically support the research groups with a portfolio of spe- cialized high-end equipment, analytical methods, and expertise.
A strong experience in analytical chemistry, cell cultures and purification methods, especially in the area of downstream pro- cessing (DSP), is at hand. In addition, one of the internationally leading laboratories in modern separation sciences and its ap- plications is present at ITV. The highly qualified staff of ITV is organized in interdisciplinary, matrix-like research teams and works with high confidentiality, if requested. ITV has 2,200 m2 of modern laboratories and pilot plants including a large set of wave bags and bioreactors up to 300 L. The platforms offer their services and know-how to industry partners such as companies from the biopharmaceutical sector. All platforms have a long and successful record of accomplishment in commissioned work for companies and scientific/applied science projects.
The comprehensive and modern analytical instrument park at ITV is organized as an analytical platform. It provides efficient support in scientific but also industrial projects and is accessible for contract work of industrial partners of ITV. The Analytical Platform works – if needed – under the quality management sys- tem ISO 17025, the microbiology section under GMP. Based on a long-term convention between the Federal Institute ofTechnology in Lausanne (EPFL), their pole ‘EPFL Valais-Wallis’ in Sion and the HES-SO Valais-Wallis, Sion, ITV has internal access to the high-end analytical instruments of the EPFL, which also leads to close scientific cooperation. Furthermore, the analytical labora- tory of ITV functions as Agilent Technologies CH demonstration laboratory for analytical equipment and applications.
At the beginning of 2021, ITV including the Analytical Platform is moving to its new building at the new and mod- ern HES-SO Valais-Wallis campus next to the EPFL common pole ‘Energypolis’, directly located at the train station of Sion.
Hereinafter we present R&D project examples where the analyti- cal chemistry & biochemistry platform was crucial in attaining project objectives.
The Analytical Platform at the Institute of Life Technologies: Examples of Established State-of-the- art Bioanalytical Applications
Proteins, particularly monoclonal antibodies (mAbs) are an important class of biotherapeutics. They have a strong presence
and sustained growth in the pharmaceutical industry nowadays.
About 70 mAbs have received first approval for human treat- ment in Europe, two in 2020.[30]They are used for a variety of indications including several forms of cancer, autoimmune and infectious diseases. Research on mAbs, but also on antibody- like compounds as for example, bispecific antibodies (bsAbs) or single chain variable fragments (scFv) and particularly antibody drug conjugates (ADC) is a growing field. Due to the upcoming patent expiry of top-selling originator products, more and more biosimilars are under development. Especially for the biosimilars comprehensive analytical characterization is needed in order to detect modifications in comparison to the originator, e.g. in the amino acid sequence or post translational modifications (PTM) as the glycosylation pattern, which may impact therapeutic ef- ficacy, bioavailability and biosafety.[31]
To be able to characterize complex biomolecules like mABs the Institute of Life Technologies has established many state-of- the-art bioanalytical tools and techniques in the last years. They allow the development as well as the quality control of e.g. com- plex proteins to be monitored, including posttranslational modi- fications. Among many others, capillary gel electrophoresis, en- zymatic sample preparation techniques, conventional as well as special LC techniques and mass spectrometry are present.
Capillary Gel Electrophoresis (CGE-SDS)
For many years, conventional sodium dodecyl sulphate–poly- acrylamide gel electrophoresis (SDS-PAGE) has been widely used to monitor identity and purity of therapeutic proteins.[32,33]
At the Analytical Platform at the Institute of Life Technologies in addition to the traditional SDS-PAGE, also CGE-SDS was imple- mented for the analysis of proteins, especially mAbs. Advantages of CGE-SDS in comparison to SDS-PAGE include short analysis time, high reproducibility, and much higher resolution. It is less laborious, does not use toxic chemicals and has the possibility of full automation using an autosampler. Proteins are detected on-capillary, usually with UV light at 220 nm. The sensitivity is comparable to the Coomassie blue staining method. In high sensitivity impurity assays, proteins can be detected down to about 10 ng/mL after labelling with a fluorescent dye and using a laser-induced fluorescence detector (LIF). This sensitivity is similar to that achieved by using silver staining in SDS-PAGE.
In Fig. 12 the analysis of an intact, non-reduced immunoglobulin (IgG) sample by CGE-SDS-UV is shown. 100µg of protein were buffer exchanged to SDS-MW Sample Buffer (Sciex, SDS-MW Analysis Kit) and alkylated with iodoacetamide at 70 °C for 5 minutes. Separation was performed with SDS-MW Gel Buffer in a 30 cm bare fused capillary at 15 kV on a ProteomeLab PA800 capillary electrophoresis system from Sciex.
This analysis is used to determine, for example, the mAb content (titer) as well as its impurities such as lower molecular
Fig. 12. Electropherogram of an IgG sample produced at Institute of Life Technologies and analyzed in the Analytical Platform laboratory; tenta- tive peak assignment.
weight fragments in a formulation. In addition, the percentage of high molecular weight species, e.g. stable aggregates and the percentage loss of one N-glycan chain or two N-glycan chains from an intact humanized mAb, are assessed and monitored dur- ing stability studies.
Mass Spectrometry (MS) Peptide Mapping
Bottom-up proteomics by proteolytic digestion of proteins prior to MS analysis is a common approach to identify proteins based on their amino acid sequence and to detect post-trans- lational modifications. The general procedure of protein iden- tification involves digestion of the intact protein using trypsin or other proteolytic enzymes followed by mass analysis of the resulting peptides. In general, tryptic digestion in solution is a time-consuming process, which is easily tainted with operator’s mistakes resulting in poor repeatability. In order to overcome those drawbacks, a workflow including an easy-to-use and quick digestion kit (Smart DigestTM, Thermo Fisher Scientific) with- out tedious sample preparation prior to accurate MS analysis (HPLC-qTOF 6530, Agilent) was established at the Institute of Life Technologies. As a result, highly reproducible digestions (RSD < 5 %, n = 3, 5 target peptides) were obtained with a sequence coverage ranging from 71 to 99% for five model pro- teins, including two different mAbs. Sample preparation time was decreased substantially. Conventional in-solution tryptic digestion takes about 16 h. Using the smart Digest™ approach, digestion time takes 20 to 60 min, depending on the protein com- plexity. For example, in Fig. 13 bovine serum albumin (BSA) was digested during 20 min leading to 96% of sequence cover- age. The protein was separated on a HPLC 1260 from Agilent equipped with a BioZen 2.6 µm Peptide XB-C18 column from Phenomenex.
Intact Mass and Drug to Antibody Ratio (DAR)
Antibody drug conjugates (ADCs) are designed for targeted treatment of a wide variety of cancers. These complex molecules, composed of a monoclonal antibody linked to a small organic biologically active cytotoxic (anticancer) payload or drug, bind to a surface antigen of the cancer cell. After phagocytosis by the cell the highly cytotoxic payload is release by e.g. lysosomal cleav- age.[15]The number of payloads per antibody is one of many key parameters that requires determination to ensure clinical efficien- cy and safety for patients. To support industrial research projects on bio-conjugation development and optimization at the Institute
of Life Technologies, a general workflow was established using mass spectrometric techniques. It comprises the determination of the intact mass of the native protein and the labelled one, the comparison of both and finally the assessment of the number of labels as well as the determination of the mean drug to an- tibody ratio (DAR). An example is shown in Fig. 14. Based on the masses detected from the unmodified and modified mAb, it was found that in total five payloads were attached to the mAb, three on the heavy chain and two to the light chain, leading to a mean DAR of 3.3. Results could be confirmed by comparing them to capillary isoelectric focusing (cIEF-UV) analysis of the same samples (data not shown). The same pattern was obtained, since cIEF separation is based on charge differences and with each payload the mAb loses one positive charge.
To conclude, the Analytical Platform of the Institute of Life Technologies possesses state-of-the-art and well-established ge- neric workflows and a wide catalogue of methods and techniques that enable the support of research projects in the area of charac- terization and quality control of complex biomolecules.
The Analytical Platform Supports the Development and Performance Evaluation of Next-generation Point-of-care Diagnostic Systems
The Diagnostic Systems Research Group, for more than a decade now, has worked on innovative solutions to address unmet needs in the field of in vitro diagnostics (IVD) and more specifi- cally point-of-care (POC) diagnostics.
The IVD domain is required to meet stringent quality stan- dards, therefore, a specialized and powerful analytical platform is necessary to ensure a detailed characterization of developed assay reagents such as derivatized proteins, labeled antibodies and modified nucleic acids (cf. Table 1) and to support valida- tion of diagnostic test performance characteristics. One of the gold standard reference methods in clinical laboratories is mass spectrometry (MS).[34,35]Hence, we have established several liq- uid chromatography (LC) coupled to MS methods ranging from quantitative therapeutic drug monitoring (TDM) to qualitative protein sequencing approaches for benchmarking purposes dur- ing the development of POC diagnostic tests.
AsanexampleinthecontextoftheNano-TeraprojectISYPEM II, a demonstrator was designed and developed for TDM of the drugs Tacrolimus, Everolimus and Tobramycin by the Diagnostic Systems research group in collaboration with the Systems Engineering Institute in order to enable personalized, continuous
Fig. 13. Base peak chromatogram (BPC) of a tryptic digest of BSA analyzed in the laboratory of the Analytical Platform‘HES-SO Sion’
with a qTOF 6530 MS from Agilent Technologies. Elution was achieved with a linear gradient of 5–70% solvent B in 90 min with a flowrate of 0.2 mL/min, where solvent A was MS grade water with 0.1% formic acid and solvent B was MS grade acetonitrile with 0.1% formic acid.
An AJS ionization source was used and MS data were acquired in the positive ion mode in the range of 100–3200 m/z at a rate of 1 Hz in extended dynamic range (2 GHz) mode with a qTOF 6530 from Agilent Technologies. Data were analyzed with BioConfirm software.
Fig. 14. Deconvoluted mass spectra of a mAbs heavy chain with dif- ferent numbers of the small payload (left) and light chains with differ- ent numbers of the small payload (right), analyzed with a qTOF 6530 from Agilent Technologies. The ADC was reduced with 5 mM DTT at 56 °C for 20 min to obtain the light and heavy chains. After dilution, the sample was separated on a HPLC 1260 from Agilent equipped with a BioZen 3.6 µm Intact XB-C8 column from Phenomenex. Elution was achieved with a gradient of 5–95 % solvent B in 20 min and a flowrate of 0.3 mL/min, where solvent A was MS grade water with 0.1% formic acid and solvent B was MS grade acetonitrile with 0.1%
formic acid. An AJS source was used and MS data were acquired in the positive ion mode in the range of 100–3200 m/z at a rate of 1 Hz in extended dynamic range (2 GHz) mode with a qTOF 6530 from Agilent Technologies. Data were analyzed with BioConfirm software.
and accurate monitoring of treatments. Measurements using the POC diagnostic demonstrator device were performed within a low-volume chamber equipped with a compact optical reader, en- abling drug quantification using a fluorescence polarization im- munoassay (FPIA). Processing of blood samples obtained from a finger prick were performed using a microfluidic cartridge.
To verify that the developed demonstrator met the challenging analytical and clinical specifications,[33]results of tested samples were compared to data obtained with LC-MS methods.[36,37]
Fig. 15 depicts the current stage of integration of the POC diag- nostic device for TDM at the HES-SO Valais-Wallis.
Another ongoing project is dedicated to the development of an innovative POC diagnostic system in order to deploy in the future a cost-effective, yet quantitative and accurate procedure
to support diagnosis of hypothyroidism with a quick TAT. The time factor is critical in the context of neurocognitive and physi- cal development disorder[38]that can occur when the disease is not treated in the first hours of human life.[39,40] In developed countries, it is usually possible to provide such diagnostic test- ing within a well establish laboratory network. However, in re- mote locations of large countries or in resource limited areas of the world, the time between collection, transport, measure- ment and finally diagnosis prior treatment can take at least three days to weeks, which is too long to prevent irreversible brain damage and growth deceleration to infants.[41] The HES-SO Valais-Wallis activities have focused on providing the bioassay based on a low-cost system and, at the same time, evaluating the performance of existing solutions by direct comparison with a quantitative LC-MS2 analytical method. Based on the support given by the Analytical Chemistry & Biochemistry Platform it was possible to determine the limited quantitative performance of commercially available rapid tests and pinpoint challenges towards a successful implementation of a next-generation POC diagnostic system.
To promote the development of new and innovative POC diagnostic solutions, the Diagnostic Systems Research Group is organizing jointly with the Swiss Center for Electronics and Microtechnology (CSEM) the 3rdSwiss Symposium in Point-of- Care Diagnostic to take place in Visp, Valais on 29 October, 2020.
This event brings together stakeholders from academia, research, medicine and industry to foster innovation in diagnostics (more information on our website: www.pocdx.ch).
Received: June 10, 2020 [1] P. Brodard, M. Dabros, R. Marti, E. Vanoli, M. Zinn, U. Frey, C. Adlhart, L.
Kind, F. Koch, F. Burgio, J. Stenqvist, S. Saxer, U. Pieles, P. Shahgaldian, S. Wendeborn, Chimia 2019, 73, 645; doi: 10.2533/chimia.2019.645.
[2] S. Kemmerling, S. A. Arnold, B. A. Bircher, N. Sauter, C. Escobedo, G.
Dernick, A. Hierlemann, H. Stahlberg, T. Braun, J. Struct. Biol. 2013, 183, 467; doi: 10.1016/j.jsb.2013.06.012.
Table 1. Project examples requiring a reference analytical method for head-to-head comparison and performance verification.
Biomarkers Envisioned POC diagnostic test Reference method Immunosuppressive
drugs
e.g. Tacrolimus
Development of a compact POC diagnostic demonstrator to perform reliable therapeutic drug monitoring (TDM) based on FPIA.
LC-MS2quantitative assay in whole blood as reference method. LC-qTOF for characterization of synthesized ligands.
Antibiotics
e.g. Tobramycin Development of a compact POC diagnostic demonstrator based on FPIA to conduct reliable TDM for newborns.
LC-MS2quantitative assay in whole blood as reference method.
Cholesterol Development of a one-step colorimetric and
electrochemical IVD quantitative assay at the POC. LC-MS2quantitative assay in whole blood as benchmark method.
Cortisol Development of a quantitative lateral flow assay. LC-MS2quantitative assay in whole blood or saliva as benchmark method.
Thyroxine (T4)
(endocrine analytics) Proof of concept study of a POC device for the diagnostic testing of hypothyroidism in newborns.
LC-MS2quantitative assay in whole blood as reference method.
Chlamydia Trachomatis
(Infectious disease) Feasibility of a POC diagnostic device for detection of Chlamydia infections based on isothermal amplification and an LFA readout.
Quantitative Realtime PCR as reference method.
Mild Traumatic Brain
Injury (mTBI) Development of an electrochemical POC
diagnostic device to diagnose mTBI on-site ELISA IVD validated method IgG/IgM COVID-19 Evaluation of the requirements to use POC diag-
nostic tests to support public health actions during the deconfinement phase of COVID-19 outbreak.
IVD laboratory-based validated methods and collaboration with clinical central laboratories.
Fig. 15. Sample-to-result workflow of the POC diagnostic system that includes capillary blood collection (1), therapeutic drug extraction (2), quantification of the drug content in a microchamber with a compact fluorescence-polarization (FP) reader (3) and data processing on a se- cured dedicated platform (4).
[3] C. Schmidli, L. Rima, S. A. Arnold, T. Stohler, A. Syntychaki, A. Bieri, S.
Albiez, K. N. Goldie, M. Chami, H. Stahlberg, T. Braun, J. Visual. Exp.:
JoVE 2018; doi: 10.3791/57310.
[4] a) J. V. Leonard, C. Dezateux, Paediat. Child Health 2011, 21, 56; doi:
10.1016/j.paed.2010.10.011; b) S. Sahoo, L. Franzson, J. J. Jonsson, I.
Thiele, Mol. bioSyst. 2012, 8, 2545; doi: 10.1039/C2MB25075F.
[5] R. Fingerhut, M. L. Silva Polanco, G. D. J. Silva Arevalo, M. A. Swiderska, Rap. Commun. Mass Spectrom. RCM 2014, 28, 965; doi: 10.1002/rcm.6856.
[6] S. Gaugler, J. Rykl, I. Wegner, T. von Däniken, R. Fingerhut, G.
Schlotterbeck, Int. J. Neonatal Screen. 2018, 4, 2; doi: 10.3390/
ijns4010002.
[7] M. Luginbühl, S. Gaugler, Clin. Biochem. 2020; doi: 10.1016/j.clinbio- chem.2020.02.007.
[8] D. Goulson, E. Nicholls, C. Botías, E. L. Rotheray, Science 2015, 347, 1255957; doi: 10.1126/science.1255957.
[9] J.-P. Faucon, L. Mathieu, M. Ribiere, A.-C. Martel, P. Drajnudel, S.
Zeggane, C. Aurieres, M. F. A. Aubert, Bee World 2002, 83, 14; doi:
10.1080/0005772X.2002.11099532.
[10] N. Desneux, A. Decourtye, J.-M. Delpuech, Ann. Rev. Entomol. 2007, 52, 81; doi: 10.1146/annurev.ento.52.110405.091440.
[11] V. Christen, M. Schirrmann, J. E. Frey, K. Fent, Environ. Science Technol.
2018, 52, 7534; doi: 10.1021/acs.est.8b01801.
[12] K. Fent, T. Haltiner, P. Kunz, V. Christen, Journal? 2020, submitted.
[13] M. Dabros, O. Vorlet, R. Marti, W. Riedl, G. Grundler, A. Vaccari, M.
Zinn, A. Ecker, C. Hinderling, Chimia 2015, 69, 482; doi: 10.2533/chi- mia.2015.482.
[14] F. Biasioli, F. Gasperi, C. Yeretzian, T. D. Märk, TrAC Trends Anal. Chem.
2011, 30, 968; doi: 10.1016/j.trac.2011.03.009.
[15] F. Biasioli, C. Yeretzian, T. D. Märk, J. Dewulf, H. van Langenhove, TrAC Trends Anal. Chem. 2011, 30, 1003; doi: 10.1016/j.trac.2011.04.005.
[16] A. N. Gloess, C. Yeretzian, R. Knochenmuss, M. Groessl, Int. J. Mass Spectrom. 2018, 424, 49; doi: 10.1016/j.ijms.2017.11.017.
[17] J. A. Sánchez-López, A. Ziere, S. I. F. S. Martins, R. Zimmermann, C. Yeretzian, J. Breath Res. 2016, 10, 36005; doi: 10.1088/1752- 7155/10/3/036005.
[18] D. Mayr, T. Märk, W. Lindinger, H. Brevard, C. Yeretzian, Int. J. Mass Spectrom. 2003, 223-224, 743; doi: 10.1016/S1387-3806(02)00967-3.
[19] D. D. Roberts, P. Pollien, N. Antille, C. Lindinger, C. Yeretzian, J. Agricult.
Food Chem. 2003, 51, 3636; doi: 10.1021/jf026230+.
[20] M. Wellinger, S. Biollaz, J. Wochele, C. Ludwig, Energy & Fuels 2011, 25, 4163; doi: 10.1021/ef200811q.
[21] S. Crelier, O. Vorlet, P. Corvini, P. Lienemann, Chimia 2018, 72, 652; doi:
10.2533/chimia.2018.652.
[22] C. Demuth, I. Poggendorf, R. Lüthi, M. Frank, K. McNeel, Gen. Engin.
Biotechnol. News 2016, 36, 22; doi: 10.1089/gen.36.12.13.
[23] C. Demuth, T. Nacke, A. Barthel, I. Poggendorf, J. Varonier, M. Eggli, 18.
Heiligenstädter Kolloquium 2016, 2016.
[24] F. Bastkowski, P. Spitzer, R. Eberhardt, B. Adel, S. Wunderli, D. Berdat, H.
Andres, O. Brunschwig, M. Máriássy, R. Fehér, C. Demuth, F. B. Gonzaga, P.
P. Borges, W. B. da Silva Junior, A. Vosp lová, M. Vi arová, S. Srithongtim, Accred. Qual. Ass. 2013, 18, 469; doi: 10.1007/s00769-013-1016-5.
[25] C. Rohrbasser, D. Rhême, S. Décastel, S. Roth, M. d. L. A. Montes, J.-L. Veuthey, S. Rudaz, Chimia 2009, 63, 890; doi: 10.2533/chim- ia.2009.890.
[26] J.-P. Bourgeois, O. Vorlet, Chimia 2018, 72, 905; doi: 10.2533/chim- ia.2018.905.
[27] L. Albergati, Master thesis HES-SO, 2020.
[28] L. Habegger, K. Rodrigues Crespo, M. Dabros, Fermentation 2018, 4, 79;
doi: 10.3390/fermentation4030079.
[29] Y. Brignoli, B. Freeland, D. Cunningham, M. Dabros, Processes 2020, 8, 679, doi: 10.3390/pr8060679.
[30] H. Kaplon, M. Muralidharan, Z. Schneider, J. M. Reichert, mAbs 2020, 12;
doi: 10.1080/19420862.2019.1703531.
[31] M. Lies, C. Lew, R. Lakshmanan, A. Guttman, Drug Discov. Devel. AB- Sciex 2018, 1.
[32] L. Zhang, B. Yeung, J. Liu, Am. Lab. 2006, 38, 34.
[33] A. Taddeo, D. Prim, J.-M. Segura, M. E. Pfeifer, J. Appl. Lab. Med. 2020, 5, 738, doi: 10.1093/jalm/jfaa067.
[34] S. E. Conklin, C. E. Knezevic, Clin. Biochem. 2020; doi: 10.1016/j.clinbio- chem.2020.03.008.
[35] A. W. S. Fung, V. Sugumar, A. H. Ren, V. Kulasingam, J. Clin. Pathol.
2020, 73, 61; doi: 10.1136/jclinpath-2019-206269.
[36] F. Aucella, V. Lauriola, G. Vecchione, G. L. Tiscia, E. Grandone, J. Pharma.
Biomed. Anal. 2013, 86, 123; doi: 10.1016/j.jpba.2013.08.001.
[37] J. Dinéia Perez, D. Sanches Aragão, F. Aparecida Ronchi, A. C. Febba, C. F. Rosso, H. Tedesco-Silva Junior, J. O. Medina de Abreu Pestana, D. E. Casarini, Transplantation Proc. 2020; doi: 10.1016/j.transpro- ceed.2020.01.077.
[38] M. D. Rappley, Med. Update for Psychiatrists 1996, 1, 64; doi: 10.1016/
S1082-7579(96)80028-8.
[39] A. J. Bauer, A. J. Wassner, Endocrine 2019, 66, 51; doi: 10.1007/s12020- 019-02024-6.
[40] F. Delange, Baillière’s Clin. Endocrinol. Metabol. 1988, 2, 637; doi:
10.1016/S0950-351X(88)80057-0.
[41] S. R. Rose, R. S. Brown,T. Foley, P. B. Kaplowitz, C. I. Kaye, S. Sundararajan, S. K. Varma, Pediatrics 2006, 117, 2290; doi: 10.1542/peds.2006-0915.